glp 1 and thyroid GLP-1 RAs Cancer: What Does the Evidence Say? | Paramesh Shamanna posted on the topic The Thyroid Twist: How GLP-1

Li CJ, Yu Q, Yu P, Yu TL, Zhang QM, Lu S, et al

These insights can help your provider tailor starting dose and titration pace, potentially reducing wasted spending on mismatched protocols and supporting faster route to an effective, affordable regimen

Apart from this, it has identified 112 other drugs and formulations that do not meet standard quality (NSQ) in its monthly drug alert for September

They work by: reducing appetite increasing feelings of fullness improving blood sugar regulation Because theyre FDA-approved, clinicians have a much clearer understanding of appropriate dosing, common side effects, and long-term safety compared to investigational drugs like retatrutide

Monitor patients for depression, suicidal thoughts, or other unusual changes in mood